81 related articles for article (PubMed ID: 7165448)
1. [Bromocriptine in Parkinson's disease. Personal experience].
Chacón JR; Piqueras L; Pery JM
Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
[No Abstract] [Full Text] [Related]
2. [Bromocriptine and Parkinson's disease: initial results].
Petit H; Destee A
Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
[No Abstract] [Full Text] [Related]
3. A comparative study of bromocriptine and levodopa in Parkinson's disease.
Duvoisin RC; Mendoza MM; Yahr MD
Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
[No Abstract] [Full Text] [Related]
4. [Bromocriptine in the treatment of Parkinson's disease].
Sepcić J; Ledić P
Neurologija; 1982; 30(1-4):75-81. PubMed ID: 6765062
[No Abstract] [Full Text] [Related]
5. [Treatment of Parkinson's disease with bromocriptine].
Castaigne P; Laplane D; Bousser MG; Bories F
Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400
[No Abstract] [Full Text] [Related]
6. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
Ulm G
Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
[No Abstract] [Full Text] [Related]
7. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
Godwin-Austen RB
Adv Biochem Psychopharmacol; 1980; 23():261-5. PubMed ID: 7395616
[No Abstract] [Full Text] [Related]
8. Bromocriptine mesylate in Parkinson's disease.
Lieberman A; Kupersmith M; Neophytides A; Casson I; Durso R; Foo SH; Khayali M; Tartaro T
N Y State J Med; 1979 Oct; 79(11):1689-92. PubMed ID: 290866
[No Abstract] [Full Text] [Related]
9. The role of bromocriptine in the treatment of Parkinson's disease.
Stern GM; Lees AJ; Shaw KM; Lander CM
Adv Biochem Psychopharmacol; 1980; 23():267-70. PubMed ID: 7395617
[No Abstract] [Full Text] [Related]
10. Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years.
Lieberman AN; Kupersmith M; Neophytides A; Gopinathan G; Casson I; Durso R; Foo SH; Khayali M; Tartaro T; Goldstein M
Adv Biochem Psychopharmacol; 1980; 23():245-53. PubMed ID: 7395614
[No Abstract] [Full Text] [Related]
11. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
12. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
Mizuno Y; Yanagisawa N; Kuno S; Yamamoto M; Hasegawa K; Origasa H; Kowa H;
Mov Disord; 2003 Oct; 18(10):1149-56. PubMed ID: 14534919
[TBL] [Abstract][Full Text] [Related]
14. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Korczyn AD; Brooks DJ; Brunt ER; Poewe WH; Rascol O; Stocchi F
Mov Disord; 1998 Jan; 13(1):46-51. PubMed ID: 9452325
[TBL] [Abstract][Full Text] [Related]
15. Early combination therapy with bromocriptine and levodopa in Parkinson's disease.
Factor SA; Weiner WJ
Mov Disord; 1993 Jul; 8(3):257-62. PubMed ID: 8341289
[TBL] [Abstract][Full Text] [Related]
16. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
Montastruc JL; Schmitt L; Bagheri H
Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
[TBL] [Abstract][Full Text] [Related]
17. Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease.
Hauser RA; Holford NH
Mov Disord; 2002 Sep; 17(5):961-8. PubMed ID: 12360545
[TBL] [Abstract][Full Text] [Related]
18. Further experiences with low doses of bromocriptine in Parkinson's disease.
Fahn S; Côté LJ; Barrett RE; Snider SR
Adv Biochem Psychopharmacol; 1980; 23():255-60. PubMed ID: 7395615
[No Abstract] [Full Text] [Related]
19. Pergolide compared with bromocriptine in Parkinson's disease: a multicenter, crossover, controlled study.
Pezzoli G; Martignoni E; Pacchetti C; Angeleri VA; Lamberti P; Muratorio A; Bonuccelli U; De Mari M; Foschi N; Cossutta E
Mov Disord; 1994 Jul; 9(4):431-6. PubMed ID: 7969210
[TBL] [Abstract][Full Text] [Related]
20. [Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients].
Liaño H; López-Lozano JJ; Ramírez A; Rabes C; Pascual ML
Arch Neurobiol (Madr); 1984; 47(3):143-50. PubMed ID: 6508478
[No Abstract] [Full Text] [Related]
[Next] [New Search]
